Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Growth stocks coverage continues on proactiveinvestors.com Go there →

Company

BioMark Diagnostics Inc

CNSX:BUX

BioMark is an oncology-focused company with advanced near-to- market liquid biopsy diagnostic technologies. The company's technology improves patient comfort, outcomes and early cancer detection. Biomark owns various intellectual properties, developed for the detection and quantitation of metabolites.

1 story